Neuroprotective effects of sevoflurane against electromagnetic pulse-induced brain injury through inhibition of neuronal oxidative stress and apoptosis

PLoS One. 2014 Mar 10;9(3):e91019. doi: 10.1371/journal.pone.0091019. eCollection 2014.

Abstract

Electromagnetic pulse (EMP) causes central nervous system damage and neurobehavioral disorders, and sevoflurane protects the brain from ischemic injury. We investigated the effects of sevoflurane on EMP-induced brain injury. Rats were exposed to EMP and immediately treated with sevoflurane. The protective effects of sevoflurane were assessed by Nissl staining, Fluoro-Jade C staining and electron microscopy. The neurobehavioral effects were assessed using the open-field test and the Morris water maze. Finally, primary cerebral cortical neurons were exposed to EMP and incubated with different concentration of sevoflurane. The cellular viability, lactate dehydrogenase (LDH) release, superoxide dismutase (SOD) activity and malondialdehyde (MDA) level were assayed. TUNEL staining was performed, and the expression of apoptotic markers was determined. The cerebral cortexes of EMP-exposed rats presented neuronal abnormalities. Sevoflurane alleviated these effects, as well as the learning and memory deficits caused by EMP exposure. In vitro, cell viability was reduced and LDH release was increased after EMP exposure; treatment with sevoflurane ameliorated these effects. Additionally, sevoflurane increased SOD activity, decreased MDA levels and alleviated neuronal apoptosis by regulating the expression of cleaved caspase-3, Bax and Bcl-2. These findings demonstrate that Sevoflurane conferred neuroprotective effects against EMP radiation-induced brain damage by inhibiting neuronal oxidative stress and apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Behavior, Animal / drug effects
  • Brain Injuries / complications
  • Brain Injuries / drug therapy
  • Brain Injuries / pathology*
  • Caspase 3 / metabolism
  • Cell Survival / drug effects
  • Cerebral Cortex / pathology
  • Cognition / drug effects
  • Electromagnetic Fields*
  • L-Lactate Dehydrogenase / metabolism
  • Male
  • Malondialdehyde / metabolism
  • Methyl Ethers / pharmacology*
  • Methyl Ethers / therapeutic use
  • Nerve Degeneration / complications
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / pathology
  • Neurons / drug effects
  • Neurons / enzymology
  • Neurons / pathology*
  • Neurons / ultrastructure
  • Neuroprotective Agents / pharmacology*
  • Oxidative Stress / drug effects*
  • Rats, Sprague-Dawley
  • Sevoflurane
  • Superoxide Dismutase / metabolism
  • bcl-2-Associated X Protein / metabolism

Substances

  • Methyl Ethers
  • Neuroprotective Agents
  • bcl-2-Associated X Protein
  • Sevoflurane
  • Malondialdehyde
  • L-Lactate Dehydrogenase
  • Superoxide Dismutase
  • Caspase 3

Grants and funding

This work was supported by the National Natural Science Foundation of China (Grants No. 30371763, No. 81071060, No. 81070997, No. 31100785 and No. 81171237), the Natural Science Foundation of Shaanxi Province (Grants No. 2006C254, No. 2011KJXX67 and No. 2013JM4040, 2012KTCG01-02,2013KTZB03-03), and the Fourth Military Medical University Foundation (Grant No. 2013-D03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.